Department of Nuclear Medicine, Rabin Medical Center, Petah Tikva, Israel.
J Nucl Med. 2010 Jul;51(7):1009-14. doi: 10.2967/jnumed.109.073130. Epub 2010 Jun 16.
We combined (18)F-FDG PET and CT enterography in a single examination and compared the level of (18)F-FDG uptake measured by maximal standardized uptake value (SUVmax) with the CT enterography patterns of disease activity found in patients with Crohn disease (CD).
Twenty-eight patients (mean age, 37.5 y; 11 male and 17 female) suspected of having active CD underwent PET/CT enterography. Abnormal bowel segments recognized on CT enterography were graded qualitatively for the presence of perienteric fat infiltration, the comb sign, and intramural attenuation and by quantitative measurements of mural enhancement (Hounsfield units) and thickness (mm). Also, for each patient, normal segments of the ileum and colon were noted, and CT enterography measurements of thickness and enhancement were obtained. For segments detected on CT enterography, a volume of interest was placed on the fused (18)F-FDG PET scan, and the SUVmax was obtained.
Of the 28 patients with suspected active CD, 22 had 85 abnormal segments and 6 had no abnormal segments. SUVmax was significantly higher in the abnormal segments than in the normal segments (5.0 +/- 2.5 [95% confidence interval, 4.5-5.5] and 2.1 +/- 0.69 [95% confidence interval, 1.9-2.2], respectively; P < 0.0001). A good correlation was found between SUVmax with CT enterography measurements of mural thickness and enhancement (P < 0.00001). There was a significant difference in SUVmax between the 3 levels of disease activity found by intramural attenuation, perienteric fat infiltration, and the comb sign on CT enterography. SUVmax was significantly higher when there were intense CT enterography findings of active disease (P < 0.001).
SUVmax assessment may allow an objective, reliable indication of the grade and severity of inflammation activity in abnormal segments of the bowel detected by CT enterography.
我们将(18)F-FDG PET 与 CT 肠造影结合在单次检查中,并比较了经最大标准化摄取值(SUVmax)测量的(18)F-FDG 摄取水平与克罗恩病(CD)患者的 CT 肠造影疾病活动模式。
28 例疑似活动性 CD 的患者(平均年龄 37.5 岁;男性 11 例,女性 17 例)接受了 PET/CT 肠造影检查。对 CT 肠造影上识别出的异常肠段进行定性分级,评估肠壁周围脂肪浸润、梳征和肠壁衰减程度,并对肠壁强化(亨氏单位)和厚度(mm)进行定量测量。同时,记录每位患者的回肠和结肠正常段,并获取 CT 肠造影厚度和强化的测量值。对于 CT 肠造影上检测到的节段,在融合(18)F-FDG PET 扫描上放置感兴趣容积,并获得 SUVmax。
28 例疑似活动性 CD 的患者中,22 例有 85 个异常段,6 例无异常段。异常段的 SUVmax 明显高于正常段(分别为 5.0 ± 2.5[95%置信区间,4.5-5.5]和 2.1 ± 0.69[95%置信区间,1.9-2.2];P<0.0001)。SUVmax 与 CT 肠造影测量的肠壁厚度和强化之间存在良好的相关性(P<0.00001)。在 CT 肠造影上发现的三种肠壁衰减程度、肠壁周围脂肪浸润和梳征之间,SUVmax 存在显著差异。当 CT 肠造影发现强烈的活动期疾病时,SUVmax 显著升高(P<0.001)。
SUVmax 评估可能为 CT 肠造影检测到的异常肠段的炎症活动程度和严重程度提供客观、可靠的指标。